THE USE OF 4-(S)-(4-ACETYL-PIPERAZIN-1-YL)-2-(R)-(4-FLUORO-2-METHYL-PHENYL)-PIPERIDINE-1-CARBOXILIC ACID, [1-(R)-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-ETHYL]-METHYLAMIDE FOR THE TREATMENT OF OVERACTIVE BLADDER - Patent 1824487

(19)

(11)

EP 1 824 487 A1

(12)

(43)	Date of publication:
	29.08.2007 Bulletin 2007/35

(21)	Application number: 05826659.4

(22)	Date of filing: 07.12.2005

(51)

International Patent Classification (IPC):

A61K 31/4995^(2006.01)

A61P 13/12^(2006.01)

(86)	International application number:
	PCT/EP2005/013205

(87)	International publication number:
	WO 2006/061233 (15.06.2006 Gazette 2006/24)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	HR

(30)

Priority:

08.12.2004 GB 0426942

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 ONN (GB)

(72)	Inventor:
	BROOKS, David, Patrick King Of Prussia, PA 19406 (US)

(74)	Representative: Dolton, Peter Irving Ernest
	GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)

(54)	THE USE OF 4-(S)-(4-ACETYL-PIPERAZIN-1-YL)-2-(R)-(4-FLUORO-2-METHYL-PHENYL)-PIPERIDINE-1-CARBOXILIC ACID, [1-(R)-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-ETHYL]-METHYLAMIDE FOR THE TREATMENT OF OVERACTIVE BLADDER